(医药健闻2026年2月13日讯)药明海德宣布其苏州基地的生物制剂灌装生产厂(DP17)已获得巴西国家卫生监督管理局(ANVISA)就布坦坦研究所(Instituto Butantan)登革热疫苗(Butantan-DV)生产项目颁发的GMP认证。DP17具备商业化液体制剂及冻干制剂的灌装能力。此次GMP认证基于ANVISA对DP17的全面现场检查,包括质量保证(QA)、质量控制(QC)、仓库及...
Source Link(医药健闻2026年2月13日讯)药明海德宣布其苏州基地的生物制剂灌装生产厂(DP17)已获得巴西国家卫生监督管理局(ANVISA)就布坦坦研究所(Instituto Butantan)登革热疫苗(Butantan-DV)生产项目颁发的GMP认证。DP17具备商业化液体制剂及冻干制剂的灌装能力。此次GMP认证基于ANVISA对DP17的全面现场检查,包括质量保证(QA)、质量控制(QC)、仓库及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.